Pam3CSK4-CDGSF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING.

Hu, Hong-Guo; Wu, Jun-Jun; Zhang, Bo-Dou; Li, Wen-Hao; Li, Yan-Mei

Pam₃CSK₄-CDG^SF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING.

Hu, Hong-Guo; Wu, Jun-Jun; Zhang, Bo-Dou; Li, Wen-Hao; Li, Yan-Mei.

Afiliação

Hu HG; Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, P.R. China.
Wu JJ; Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, P.R. China.
Zhang BD; Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, P.R. China.
Li WH; Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, P.R. China.
Li YM; Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, P.R. China.

Bioconjug Chem ; 31(11): 2499-2503, 2020 11 18.

Article em En | MEDLINE | ID: mdl-33147965

Assuntos

Imunoterapia; Lipopeptídeos/farmacologia; Proteínas de Membrana/agonistas; Neoplasias/terapia; Receptor 2 Toll-Like/agonistas; Animais; Formação de Anticorpos; Linfócitos T CD4-Positivos/imunologia; Linfócitos T CD8-Positivos/imunologia; Humanos; Imunidade Celular; Camundongos; Neoplasias/imunologia; Receptor 1 Toll-Like/agonistas

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 2 Toll-Like / Lipopeptídeos / Imunoterapia / Proteínas de Membrana / Neoplasias Limite: Animals / Humans Idioma: En Revista: Bioconjug Chem Assunto da revista: BIOQUIMICA Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google